Compare ENR & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENR | SANA |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | N/A | 2021 |
| Metric | ENR | SANA |
|---|---|---|
| Price | $19.75 | $4.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $27.00 | $7.83 |
| AVG Volume (30 Days) | 943.2K | ★ 3.0M |
| Earning Date | 02-05-2026 | 11-06-2025 |
| Dividend Yield | ★ 5.80% | N/A |
| EPS Growth | ★ 538.46 | N/A |
| EPS | ★ 3.32 | N/A |
| Revenue | ★ $2,952,700,000.00 | N/A |
| Revenue This Year | $2.65 | N/A |
| Revenue Next Year | $1.09 | N/A |
| P/E Ratio | $6.23 | ★ N/A |
| Revenue Growth | ★ 2.28 | N/A |
| 52 Week Low | $16.77 | $1.26 |
| 52 Week High | $35.83 | $6.55 |
| Indicator | ENR | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 44.33 | 52.01 |
| Support Level | $20.85 | $4.37 |
| Resistance Level | $21.90 | $4.92 |
| Average True Range (ATR) | 0.76 | 0.30 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 27.85 | 64.65 |
Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.